Optimal Range for Parvalbumin as Relaxing Agent in Adult Cardiac Myocytes: Gene Transfer and Mathematical Modeling  by Coutu, Pierre & Metzger, Joseph M.
Optimal Range for Parvalbumin as Relaxing Agent in Adult Cardiac
Myocytes: Gene Transfer and Mathematical Modeling
Pierre Coutu* and Joseph M. Metzger†
Departments of *Biomedical Engineering and †Physiology, University of Michigan, Ann Arbor, Michigan 48109 USA
ABSTRACT Parvalbumin (PV) has recently been shown to increase the relaxation rate when expressed in intact isolated
cardiac myocytes via adenovirus gene transfer. We report here a combined experimental and mathematical modeling
approach to determine the dose-response and the sarcomere length (SL) shortening-frequency relationship of PV in adult rat
cardiac myocytes in primary culture. The dose-response was obtained experimentally by observing the PV-transduced
myocytes at different time points after gene transfer. Calcium transients and unloaded mechanical contractions were
measured. The results were as follows. At low estimated [PV] (0.01 mM), contractile parameters were unchanged; at
intermediate [PV], relaxation rate of the mechanical contraction and the decay rate of the calcium transient increased with little
effects on amplitude; and at high [PV] (0.1 mM), relaxation rate was further increased, but the amplitudes of the mechanical
contraction and the calcium transient were diminished when compared with control myocytes. The SL shortening-frequency
relationship exhibited a biphasic response to increasing stimulus frequency in controls (decrease in amplitude and re-
lengthening time from 0.2 to 1.0 Hz followed by an increase in these parameters from 2.0 to 4.0 Hz). The effect of PV was to
flatten this frequency response. This flattening effect was partly explained by a reduction in the variation in fractional binding
of PV to calcium during beats at high frequency. In conclusion, experimental results and mathematical modeling indicate that
there is an optimal PV range for which relaxation rate is increased with little effect on contractile amplitude and that PV
effectiveness decreases as the stimulus frequency increases.
INTRODUCTION
Parvalbumin (PV) is an 11-kD protein that belongs to the
EF-hand family of calcium (Ca2) binding proteins (Pauls
et al., 1996). PV has two metal binding sites, with high
affinity for calcium (Kpvca  10
7–109 M1) and moderate
affinity for magnesium (Kpvmg  10
3–105 M1), with the
exact binding constants being species and measurement
condition dependent (Pauls et al., 1996). PV is naturally
expressed in fast skeletal muscles of vertebrates and in the
brain and endocrine glands of mammals (Eberhard and
Erne, 1994). In particular, PV’s role in fast skeletal muscles
has been postulated to involve delayed calcium buffering to
increase the relaxation rate (Hou et al., 1992, 1991, West-
erblad and Allen, 1994, Rall, 1996, Heizmann et al., 1982).
Although PV is not the only requirement for fast relaxation,
there is a strong positive correlation between PV concen-
tration and the relaxation rate in mammalian (Heizmann et
al., 1982) and frog (Hou et al., 1991) skeletal muscles. In
this regard, the toadfish swim bladder muscle is known to be
one of the fastest relaxing muscles in the vertebrate world
(t1/2R  5 ms) (Feher et al., 1998), and it has one of the
highest concentrations of PV ([PV]  3 mM) (Rome and
Klimov, 2000).
The mechanism for the increase in relaxation rate in fast
skeletal muscles due to PV is tightly linked to its delayed (or
slow) calcium buffering action (Rall, 1996). The ability of
PV to accelerate relaxation in striated muscles can be ex-
plained as follows. Under physiological conditions at rest
(free [Mg2]  1 mM and [Ca2]  10–100 nM), a large
fraction of the PV metal-binding-site population is occupied
by magnesium. Upon stimulation, intracellular calcium rises
to micromolar levels, causing a fraction of the total divalent
binding site population to switch from the magnesium to the
calcium-bound state. However, unbinding of magnesium
from PV is a relatively slow process (kpvmg
  3.42 s1 in
frog at 20°C (Hou et al., 1992)). This slow unbinding of
magnesium from PV causes formation of the PV-Ca2
complex to be delayed when compared with the time course
of the rapid transient increase in intracellular free calcium.
Due to this delayed action, the amount of calcium buffered
during the rapid rising phase of the calcium transient is
minimized, whereas after the peak of the calcium transient
a significant amount of calcium is buffered. The significant
buffering of calcium after the peak of the transient, i.e.,
during the early decay phase, causes the calcium transient
and consequently the mechanical contraction to decay more
rapidly. However, at high PV concentrations, it is possible
that even the small increase in the fraction of the PV
buffering sites occupied by calcium could lead to a depres-
sion in the peak amplitude of the calcium transient. To our
knowledge, little attention has been paid to this in the
literature (Rome et al., 1999).
Although not present endogenously in cardiac muscles,
Wahr et al. (1999) have been able to express PV in intact
cardiac myocytes via adenovirus gene transfer technology.
Using this technique, PV has been successfully expressed at
sub-millimolar concentrations in adult rat cardiac myocytes
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and has been shown to increase the rate of decay of the
calcium transient and the relaxation rate of the mechanically
unloaded contraction (Wahr et al., 1999). However, little is
known about the quantitative effects of PV concentration on
mechanical contraction and calcium transient properties in
adult cardiac myocytes.
In this study, we sought to determine the direct effects of
PV concentration on the relaxation and contraction proper-
ties of membrane intact adult cardiac myocytes in short-
term primary culture. We show here the PV dose-response
relationship for calcium transients and mechanically un-
loaded contractions. In particular, attention is placed on the
dual effects of PV on the calcium transient: the amplitude
attenuation and the acceleration of the decay. We tested the
hypothesis that at low PV concentrations there would be no
change in mechanical contraction (and/or Ca2 transient)
properties, whereas high PV concentrations would result in
highly increased relaxation rates with some degree of atten-
uation in the amplitude of the contraction (and/or Ca2
transient). However, for a given range of intermediate PV
concentrations, we hypothesize an ideal case where the
contractile amplitude is not reduced significantly whereas
the relaxation rate would be increased. This experimentally
derived optimal range for PV effects is of critical impor-
tance in the case if PV is to be considered as a possible
experimental approach to correct diastolic dysfunction in
vivo (Szatkowski et al., 2001). Indeed, in diastolic dysfunc-
tion, the slowed decay of the calcium transient at the myo-
cyte level (Morgan, 1991) can initiate maladaptive growth
at the organ level that could lead ultimately to development
of arrhythmia, heart failure, and possibly sudden death
(Spirito et al., 2000). In this case, it would be of great
importance to improve relaxation speed without impairing
the contractile inotropic properties of the heart.
The second main aim of this study involved the determi-
nation of the sarcomere length (SL) shortening-frequency
relationship in cardiac myocytes in the presence of PV. The
SL shortening-frequency relationship is important to ad-
dress as the dynamic range of the mammalian heart varies
from 0.5 to 10 Hz depending on species (human,1 Hz; rat,
6 Hz; mouse, 10 Hz). During tetanic stimulation of fast
skeletal muscles, PV-Ca2 binding sites become saturated,
thus limiting the relaxation enhancement of PV (Hou et al.,
1992). We therefore hypothesized that in cardiac myocytes,
the hastening effects of PV on relaxation will be diminished
as the stimulus rate increases. The final aim of this work
involved constructing mathematical models that incorporate
the effects of PV in the presence of different calcium
conditions to aid in the interpretation of the results obtained.
METHODS
Solutions
During the myocyte isolation procedure, Krebs-Hensleit buffer (KHB),
KHBCa2, KHBCa2BSA, and a digestion enzyme solution (DES)
were the principal solutions used. KHB consisted of 118 mM NaCl, 25 mM
HEPES, 11 mM glucose, 4.8 mM KCl, 1.2 mM KH2PO4, and 1.2 mM
MgSO4, and the pH was adjusted to 7.4 with HCl. For the KHBCa
2, 1.0
mM CaCl2 was added to the KHB solution. Bovine serum albumin (BSA)
was added to the KHBCa2 (final concentration 2%) to form the
KHBCa2BSA solution. DES consisted of KHB mixed with hyaluron-
idase (Sigma Chemical Co., St. Louis, MO) and collagenase (Worthington
type II) (final concentration 0.02% and 0.04%, respectively).
For the myocyte plating and primary culture the following solutions
were used: DMEM/PSFBS (plating), DMEM/PS (quiescent cultured
myocytes), and M199 (electrically stimulated cultured myocytes).
DMEM/PS was made of Dulbecco’s minimal essential medium (DMEM)
stock with 50 U/ml penicillin/streptomycin (P/S) (all from GibcoBRL,
Gaithersburg, MD). For the DMEM/PSFBS version, fetal bovine serum
(FBS; from GibcoBRL) was added to DMEM/PS for a final concentration
of 5%. Finally, M199 consisted of Media 199 stock (Sigma) supple-
mented with 10 mM glutathione, 26.2 mM sodium bicarbonate, 0.02%
BSA, and 50 U/ml P/S, and the pH was adjusted to 7.4 with NaOH.
For immunofluorescence (IF) experiments, the blocking solution (IF-
BS) was made of 20% normal goat serum (NGS) in PBS whereas the
antibody solution (IF-AB) consisted of PBS plus 2% NGS plus 0.5% Triton
X-100 (TX-100). For Western blot (WB) experiments, the blocking solu-
tion (WB-BS) and the antibody solution (WB-AB) were made of 5% dry
milk in Tris-buffered saline. For all PV-related WB experiments, 0.05% of
polyoxyethylene-sorbitan monolaurate (Tween-20) was incorporated in the
solutions.
Myocyte isolation and gene transfer
Adult cardiac myocytes were isolated from Sprague-Dawley rats (200–250
g) as described previously (Westfall et al., 1997). The isolated myocytes
were then plated on laminin-coated coverslips (density of 20,000 rod-
shaped myocytes/coverslip) in DMEM/PSFBS solution for 2 h. The
myocytes were incubated with either DMEM/PS solution (control myo-
cytes) or with DMEM/PS solution mixed with adenovirus (PV or Lac-Z-
transduced myocytes) for an additional hour (Westfall et al., 1997). An
optimal multiplicity of infection of 500 plaque-forming units per myocyte
(Wahr et al., 1999) was used for both adenoviruses. The myocytes were
cultured for up to 4 days in DMEM/PS media as described in Westfall et
al. (1997). All perfusion, digestion, and incubation steps were performed at
37°C.
Electrical stimulation
The coverslips containing myocytes used for mechanical and calcium
experiments were transferred to special stimulating chambers 18 h after
gene transfer. The chambers (2.5 cm  3.5 cm) are made of Plexiglas and
contain two platinum electrodes each. The chambers were connected to a
custom electrical stimulator and a power amplifier (Crown DC-300A). The
stimulator supplied a square-wave pulse of 2.5-ms duration at a frequency
of 0.5 Hz. The amplitude of the pulse was adjusted such that 50% of the
myocyte population was contracting (Wahr et al., 1999). The media used
was the M199 solution and was replaced every 12 h.
Parvalbumin expression
The procedure for immunofluorescence detection has been described pre-
viously (Westfall et al., 1997). Briefly, coverslips with plated myocytes
were fixed with 3% paraformaldehyde/PBS fixative solution for 30 min,
treated in blocking solution (IF-BS) for 30 min, followed by a 90-min
exposure to primary antibody Parv-19 (Sigma) mixed with IF-AB solution
(dilution of 1:1000). After another 30-min blocking period in IF-BS, the
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coverslips were exposed to the secondary antibody (goat anti-mouse IgG-
Texas Red from Molecular Probes, Eugene, OR; dilution 1:100 in IF-AB).
Western blot experiments were performed as described previously
(Westfall et al., 1997). For each sample, the myocytes from two coverslips
were scraped and stored in SDS-polyacrylamide gel electrophoresis buffer
at 20°C until use. Primary antibodies Parv19 and 5c5 (both from Sigma)
were used, respectively, to detect parvalbumin and -actin. Dilution of
1:1000 and 1:50,000 in WB-AB were used for Parv-19 and 5c5, respec-
tively. In both cases, goat anti-mouse antibody conjugated to horseradish
peroxidase (Sigma A-9917; dilution 1:1000 in WB-AB) was used as the
secondary antibody. The detection was performed using the enhanced
chemiluminescence technique. Samples collected from rat superior vastus
lateralis (SVL) muscle were used as a positive control. For all PV samples,
the level of PV expression was normalized to the level of actin expression.
The same normalization was also performed on the positive control (SVL).
Finally, the PV/actin ratio of PV-transduced myocytes was normalized to
the PV/actin ratio of SVL samples to give the estimated PV concentration
in myocytes relative to the PV level in SVL. The estimated PV concen-
tration in myocytes is based on a value of 0.4 mM reported for PV
concentration in rat SVL (Green et al., 1984).
Calcium transients
Coverslips were mounted on a custom microscope stage and were kept at
37°C for all experiments. The myocytes were loaded for 6 min in M199
solution containing 5 M fura-2AM (from Molecular Probes) and 0.01%
of Pluronic F-127 (from Molecular Probes). After three washes, the myo-
cytes remained in M199 solution for the measurements. A 5-min period
was allowed for de-esterification. Fluorescence was measured using a
microscope-based high-speed ratio fluorescence spectrometer (model
M-40 from Photon Technology International, Lawrenceville, NJ). The
myocytes were electrically stimulated at a frequency 0.2 Hz, and the
fluorescence ratio (340 nm/380 nm) was sampled at 100 Hz. Ten sample
traces were collected and averaged for each studied myocyte. Smoothing
with immediate adjacent time points was performed to reduce noise level.
No attempt was made to convert fluorescence ratio into absolute calcium
level. The times from stimulus to peak (tP(Ca)), to half decay (tS-1/2D(Ca)),
and to three-fourths decay (tS-3/4D(Ca)) were recorded. Curve fitting using
custom-fit functions in software Igor (from WaveMetrics, Tucson, AZ)
was performed. The decay portion of the curves (from 10% decay to 800
ms after stimulus) were fitted to single- and double-exponential functions.
Mechanical measurements
The mechanical measurements used the same stage as in the calcium
measurements, and the myocytes were also maintained at 37°C in M199
solution. A HeNe laser diffraction system was used to directly measure the
sarcomere length dynamics. A calibrated projection screen was used to
estimate the absolute sarcomere length (at	0.05 m). A linear continuous
position detector (model LSC-30D from United Detector Technology,
Baltimore, MD) was used to collect the position of the first-order diffrac-
tion pattern at a sampling rate of 5 kHz as described in Wahr et al. (1999).
For the SL shortening study, myocytes were electrically stimulated at 0.2
Hz, and 10 traces were recorded and averaged per myocyte. For the SL
shortening-frequency relationship, the myocytes were submitted to at least
15 beats at each frequency, and 3 of the subsequent beats were recorded
and averaged. The frequencies used, in order, were 0.2, 0.5, 1.0, 2.0, and
4.0 Hz. The times from stimulus to peak (tP), from peak to half re-
lengthening (t1/2R), from stimulus to half re-lengthening (tS-1/2R), and from
half shortening to half re-lengthening or half-width time (t1/2W) were
recorded. The shortening traces were normalized with respect to their
amplitudes, and their maximal positive and negative time derivatives were
also measured (dl/dtmax and dl/dtmax).
Mathematical models
Calcium and magnesium binding to PV was calculated using the following
equations:
dPvca
dt
 kpvca
 
Ca1 Pvca Pvmg kpvca
 Pvca
(1)
dPvmg
dt
 kpvmg
 
Mg1 Pvca Pvmg kpvmg
 Pvmg,
(2)
in which Pvca and Pvmg are the fraction of the PV population binding sites
bound with calcium and magnesium, respectively, and kpvca
 , kpvmg
 , kpvca
 ,
and kpvmg
 are the on and off rate constants of this reaction.
The affinity values used in this paper were obtained from rat PV data at
35°C (Eberhard and Erne, 1994), and are 0.91  108 M1 and 2.43  104
M1 for calcium and magnesium, respectively. The off rates were extrap-
olated in temperature from frog PV data (Hou et al., 1992), and are kpvca
 
4.03 s1 and kpvmg
  10.58 s1. The on rates were simply calculated from
the affinities and the off rates to give: kpvca
  3.66  108 M1 s1 and
kpvmg
  25.71 104 M1 s1. The magnesium concentration was assumed
to be of fixed value at 1.0 mM (Godt and Maughan, 1988).
In this study, three different mathematical models incorporating Eqs. 1
and 2 were used: 1) fixed calcium concentration model, 2) fixed calcium
transient model, and 3) fixed calcium release model.
In the fixed calcium concentration model, the free calcium concentra-
tion ([Ca2]) is used as the stimulus variable using step functions. In this
model, PV levels are assumed to be small, therefore not affecting free
calcium or magnesium concentrations. The intent of this model is to obtain
insights on the kinetics and steady-state values of the fractional binding of
PV (Pvca, Pvmg, Pvfree  1  Pvca  Pvmg) under a fixed level of free
calcium.
The fixed calcium transient model is similar to the fixed calcium
concentration model. Free calcium is still being used as the control vari-
able, but a representative calcium transient function is used instead of step
functions. This model is used to evaluate the effect of increasing frequency
of stimulus on fractional binding of PV. The equation for the calcium
transient (Eq. 3) was derived empirically to obtain a calcium transient that
has a time to peak of 20 ms, an exponential decay with   40 ms, and
a basal and peak level of calcium of 0.1 and 1.0 M, respectively. The term
to the 8th power is there to ensure that the calcium transient returns to
resting level after 250 ms to minimize inter-beat discontinuities at the
highest frequency (4 Hz).

Ca 0.0001 mM
0.0019 mM
1 t/210 ms)8
 exp(t/40 ms) exp(t/10 ms) (3)
The fixed calcium release model is a simplistic version of the myocyte
cytoplasmic environment. The purpose of this model is to evaluate the
effect of PV on free cytoplasmic calcium concentration during a transient.
The model contains a calcium release subunit, a calcium uptake subunit,
and calcium cytoplasmic buffers. The calcium release subunit, which
represents mostly the calcium release from the sarcoplasmic reticulum
(SR), is represented by the following equation:
Jrel t/12.0 ms)expt/12.0 ms0.00487 mM/ms (4)
This equation was derived empirically to resemble the rat cardiac
myocyte calcium transient (based on our data; see, e.g., Fig. 3 A) in the
presence of calmodulin and troponin. The calcium uptake subunit, which
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represents mostly uptake via SR Ca2 ATPase, is based on the model by
Shannon et al. (2000). The equations can be found in Winslow et al.
(1999), where they were used in the context of canine cardiac myocytes.
The parameter KSR (the scaling factor for calcium ATPase; see Winslow
et al., 1999) was changed from 1.0 to 2.3, and [Ca]NSR (the calcium
concentration inside the SR; see Winslow et al., 1999) was fixed at 0.262
mM to make the calcium transient decay more rat-like (based on our data;
see, e.g., Fig. 3 A). The equations for the endogenous calcium buffers are
very similar to Eqs. 1 and 2 and are given, along with their parameters, in
Robertson et al. (1981) and Winslow et al. (1999) for calmodulin and
troponin respectively. PV buffering Eqs. 1 and 2 were also added to the
model. PV concentration was used as a variable from simulation to sim-
ulation. The free calcium concentration was then calculated as follows:
d
Ca
dt
 Jrel Jup Jpvca Jhtrpn Jltrpn
 Jcmdn (mM/ms), (5)
where Jrel and Jup are the release and uptake calcium fluxes, respectively,
whereas Jpvca, Jhtrpn, Jltrpn, and Jcmdn are the buffering calcium fluxes
to PV, troponin C high- and low-affinity binding sites, and calmodulin,
respectively (Winslow et al., 1999).
For all models, the resulting set of differential equations was solved
using a custom program written in C using the fourth order with adaptive
time step Runge-Kutta-Merson algorithm (Gerald and Weathley, 1985).
These models were chosen to keep external variables under tight control
and focus the attention on the role of PV in cardiac myocyte relaxation.
Statistical analysis
All statistical analysis was performed using GraphPad Instat software.
One-way ANOVA was used to determine whether there were any signif-
icant differences among multiple groups of data. When there was a sig-
nificant difference, a Student-Newman-Keuls multiple comparison test was
performed to determine which individual groups were different. Values are
presented as means along with their standard error.
RESULTS
Parvalbumin expression
Adenovirus gene transfer technology has been shown to
provide a highly efficient tool to deliver genes into intact
adult cardiac myocytes (Westfall et al., 1997). In the present
study, we used recombinant adenovirus (E1A deleted) vec-
tors containing either the human -PV or the Lac-Z gene
(used as a virus control) with transcription driven by the
cytomegalovirus promoter (Wahr et al., 1999). To verify the
success of gene transfer, we used two different techniques.
First, to evaluate the percentage of rod-shaped cardiac myo-
cytes that have been transduced successfully, we used indi-
rect immunofluorescence techniques. Second, to obtain
quantitative values for the level of protein expression, we
used Western blot techniques. Results of the immunofluo-
rescence experiment are presented in Fig. 1. Fig. 1, A and B,
were taken from coverslips containing PV-transduced myo-
cytes at days 2 and 4 after gene transfer, respectively. The
number of rod-shaped myocytes that were PV positive was
greater than 95% on day 2 and greater than 99% on days 3
and 4 (n  100 for each case), indicating a high efficiency
and synchronization of PV expression using adenovirus
gene transfer technology.
To obtain a quantitative estimate of PV concentration,
Western blot analysis of cardiac myocytes along with rat
fast twitch muscle standards was used (Fig. 2). As expected,
no PV was detected in non-transduced control cardiac myo-
cytes. PV expression increased as a function of days after
gene transfer with PV first detected on day 2.0 after gene
transfer ([PV]  0.014 	 0.005mM). Levels at day 5 were
estimated in three experiments and did not show appreciable
difference from day 4, indicating apparent saturation (data
not shown). The estimated concentration of PV (day 4) in
cardiac myocytes was 47.4 	 5.2% of the amount of PV
naturally expressed in SVL muscle. Assuming a SVL PV
concentration of 0.4 mM (Green et al., 1984), this corre-
sponds to an estimated PV concentration of 0.19 	 0.02
mM in cardiac myocytes.
Calcium transients
Fura-2AM fluorescence (ratio, 340 nm/380 nm) was mea-
sured using single twitch contractions (frequency 0.2 Hz)
in cardiac myocytes. The results are summarized in Table 1.
Representative calcium transients for control, Lac-Z-, and
PV-expressing cardiac myocytes (all on day 3 after gene
transfer) are presented in Fig. 3 A. PV-expressing cardiac
myocytes exhibited hastened early decay when compared
with either control or Lac-Z myocytes but slower decay
toward the end of the transient.
For control cardiac myocytes, the tS-1/2D(Ca) and the fitted
decay time constant () for control myocytes at days 2, 3,
and 4 were examined. The result showed no significant
differences in calcium transient dynamics; therefore, the
control myocytes data from days 2–4 were pooled together.
The Lac-Z-transduced myocytes from days 2–4 were also
pooled together as their calcium transient dynamic param-
eters were unchanged over that time period. Fig. 3 B shows
tS-1/2D(Ca) for the three myocyte groups. The pooled control
and Lac-Z myocytes exhibited no differences in their
tS-1/2D(Ca), whereas at day 2 the PV-expressing myocytes
showed a moderate but statistically significant reduction in
tS-1/2D(Ca) when compared with the control myocytes. This
reduction in decay time was more pronounced by days 3 and
4 for PV-expressing myocytes. The tS-3/4D(Ca) was also
determined (Table 1). In this analysis, only day 3 PV-
expressing myocytes showed a significant reduction in
tS-3/4D(Ca) when compared with control. This indicates that,
in PV-expressing myocytes, the early part of the decay
process is accelerated but not the later part. This phenom-
enon will be addressed in the Discussion.
To more completely assess the calcium transients, the
traces were fit with single- and double-exponential func-
tions (results in Table 1). The fit started at 10% of the decay
and ended at 800 ms after stimulation. All control and
Lac-Z-transduced myocytes were well fit by single-expo-
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nential functions (Fig. 4 A). Fitting a double exponential did
not visually improve the quality of the fit in most cases. To
confirm this visual impression, a 2 test was performed on
each fit. On average, the 2 value was reduced by only
16.5 	 2.3% for the control and by 20.9 	 2.4% for the
Lac-Z myocytes. However, for 80% of the PV-transduced
myocytes, there was a striking visual improvement by going
from the single- to the double-exponential fit (Fig. 4 B).
Moreover, the 2 value was reduced, on average, by 70.0 	
2.3%, 62.3 	 3.0%, 66.6 	 3.2% on days 2, 3, and 4,
respectively, for this group. The remaining 20% of the PV
population showed only a 17.4 	 6.5% reduction in 2
value when going from single- to double-exponential fit.
The double-exponential fit was rejected if at least one of the
following conditions was met: small reduction in 2 value
(20%), small contribution of the slow component (3%),
the slow and fast time constant were identical (within 5%),
or the slow time constant was 3 SD away from the mean.
In the double-exponential fit of PV-expressing myocytes
the slow component contributed 14.6	 1.1%, 11.9	 1.1%,
and 13.3 	 1.0% of the total amplitude for days 2, 3, and 4,
respectively (not significantly different from each other).
The slow time constant was 0.954	 0.110 s, 0.898	 0.072
FIGURE 1 Immunofluorescence detection of PV in rat adult cardiac myo-
cytes. (A) PV-transduced myocytes on day 2 post gene transfer (PGT); (B)
PV-transduced myocytes on day 4 PGT; (C) Control myocytes on day 4. The
main panels show myocytes treated with primary antibody Parv-19 and sec-
ondary antibody anti-mouse IgG-Texas Red. Images were taken using fluo-
rescence microscopy. The calibration bar in A indicates a length of 100 m.
The insets show the same myocytes under IDC-bright field illumination.
FIGURE 2 Western blot analysis of PV expression at different time
points post gene transfer (PGT). (A) Representative Western blot. The top
row is PV expression, and the bottom row is the actin expression (used for
the normalization). As expected, control myocytes (C) show no traces of
endogenous PV, whereas PV expression increases as function of days PGT
in PV-transduced myocytes. (B) Summary of estimated [PV] versus days
PGT. The results in myocytes were scaled relative to SVL. The [PV]SVL
was assumed to be equal to 0.4 mM (Green et al., 1984). Values are mean
with SEM (n  10–16).
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s, and 1.060 	 0.103 s on days 2, 3, and 4, respectively
(not significantly different from each other). A summary
of the fast (or single) time constant values is presented in
Fig. 4 C. The fast time constant is shown for the 80% of
the PV population that was better fit with a double
exponential whereas the single time constant is shown for
the remaining 20% of the PV myocyte population. Over-
all, there was a large and significant reduction in the fast
time constant, especially on days 3 and 4 for PV-express-
ing myocytes when compared with the control myocytes.
A possible cellular basis for the double-exponential fit
for the PV-transduced myocytes will be addressed in the
Discussion.
Mechanical measurements
Using the laser diffraction technique, the kinetics of un-
loaded sarcomere shortening were measured. A summary of
the results is presented in Table 1. Representative data are
shown in Fig. 5 A for day 3 control, Lac-Z-, and PV-
expressing myocytes. The tS-1/2R for each myocyte group is
summarized in Fig. 5 B. In control and Lac-Z myocytes, the
tS-1/2R was not significantly altered over time in primary
culture. Therefore, for both control and Lac-Z groups, data
from all days (1.0, 2.0, 3.0, and 4.0) were pooled together.
At day 2, PV-expressing myocytes did not show any sig-
nificant reduction in tS-1/2R. However, starting at day 2.5
and increasing through day 4, tS-1/2R for PV-expressing
myocytes was significantly shorter, indicating a faster rate
of relaxation as a function of increased PV expression (Fig.
2 B).
A calibrated screen was used to measure the resting SL
and contraction amplitude. The resting SL of individual
myocytes ranged from 1.6 to 1.9 m, with averages ranging
from 1.76 to 1.80 m per group. A summary of the effects
of PV expression on the amplitude of SL shortening is
presented in Fig. 5 C. The day 1 to day 4 data were pooled
together for control and Lac-Z myocytes. The control,
Lac-Z, and the initial days PV data (days 1.0, 2.0, and 2.5)
showed no significant differences in the amplitude of short-
ening. However, at days 3.0 and 4.0, the contraction ampli-
tude for PV-expressing myocytes was smaller than the
control. It should be noted that for PV myocytes on day 2.5,
the amplitude of contraction was not significantly altered
whereas the tS-1/2R was significantly reduced. This point
will become important in determining the optimal level of
TABLE 1 Summary of calcium transient and sarcomere shortening measurements
Control
(pooled)
Lac-Z
(pooled)
PV
Day 1 Day 2 Day 2.5 Day 3 Day 4
Calcium transient
n 105 105 – 26 – 48 49
tP(Ca) (ms) 49.0 (1.5)* 49.2 (1.6) – 39.2 (1.6) – 42.7 (1.8)
† 43.9 (2.2)‡
tS1/2D(Ca) (ms) 180.5 (2.5) 178.4 (2.8) – 159.6 (4.4)
§ – 142.7 (3.9)¶ 143.5 (4.6)¶
tS3/4D(Ca) (ms) 273.1 (4.4) 275.6 (5.7) – 280.2 (11.3) – 245.8 (9.5)
 258.7 (8.3)
n (single-exponential fit) 105 105 – 4 – 11 10
 (ms) 151.0 (3.8) 157.9 (5.0) – 124.7 (13.5) – 136.9 (8.1) 129.4 (6.9)
n (double-exponential
fit)
– – – 22 – 37 39
ASLOW (%) – – – 14.6 (1.1) – 11.9 (1.1) 13.3 (1.0)
SLOW (ms) – – – 954 (110) – 898 (72) 1060 (103)
FAST (ms) – – – 114.7 (5.8) – 75.4 (3.6) 78.7 (3.9)
Sarcomere shortening
n 175 149 54 61 52 63 59
Amplitude (nm) 96.1 (2.1) 95.0 (2.3) 99.1 (3.1) 94.4 (3.3) 93.5 (4.7) 82.3 (4.0) 73.2 (3.6)¶
tP (ms) 47.4 (0.7) 47.6 (0.7) 51.1 (1.2)
§ 45.8 (1.3) 41.7 (1.1)¶ 37.3 (0.9)¶ 37.4 (1.0)¶
tP1/2R (ms) 23.5 (0.6) 23.9 (0.6) 23.4 (1.0) 21.9 (1.2) 21.0 (1.0) 19.2 (1.2)
§ 17.3 (0.9)¶
tS1/2R (ms) 70.9 (1.0) 71.5 (0.9) 74.5 (1.6) 67.7 (1.9) 62.7 (1.6)
§ 56.5 (1.7)¶ 54.7 (1.5)¶
t1/2W (ms) 50.0 (1.0) 50.4 (0.9) 53.4 (1.7) 47.9 (1.8) 43.8 (1.5)
§ 38.9 (1.8)¶ 35.3 (1.3)¶
dl/dt max (1/s) 54.3 (1.1) 54.3 (1.1) 50.5 (1.6) 54.2 (1.7) 62.3 (2.6)¶ 69.7 (1.8)¶ 69.7 (2.2)¶
dl/dt max (1/s) 45.1 (1.3) 44.0 (1.0) 44.1 (2.5) 44.6 (2.1) 50.3 (2.1) 54.7 (2.6)¶ 59.5 (2.6)¶
Control and Lac-Z measurements taken at different days after gene transfer were pooled into a single group. tP(Ca), tS1/2D(Ca), and tS3/4D(Ca) represent the
time from stimulus to peak, time from stimulus to half and three-fourths decay of the calcium transients, respectively.  represents the time constant for
the single-exponential fit, whereas ASLOW, SLOW, and FAST are the relative contribution of the slow component, the slow time constant, and the fast time
constant, respectively, for the double-fitted calcium transient decay. tP, tP1/2R, tS1/2R, t1/2W, dl/dt max, and dl/dt max are the time to peak, time from
peak to half re-lengthening, time from stimulus to half re-lengthening, time of half-width, and the maximal positive and negative time derivatives of
normalized sarcomere shortening, respectively. Values are indicated as means with SEMs in parentheses. n, number of myocytes per group.
*Control data TP(Ca) showed significant differences between daily values (41.9 	 1.9 ms, 54.7 	 2.4 ms, and 50.3 	 3.0 ms for days 2, 3, and 4,
respectively); the data were pooled only for completeness.
†‡Values significantly different from control data from the corresponding day: †p  0.001; ‡p  0.05.
§¶Values significantly different from pooled control values: §p  0.01; ¶p  0.001; p  0.05.
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PV for which contraction relaxation is faster but its ampli-
tude is not impaired (see Discussion).
In another set of experiments, the effects of PV expres-
sion on SL shortening-frequency relationship was deter-
mined. The stimulation frequency was varied from 0.2 to 4
Hz. For each frequency, a minimum of 15 beats was al-
lowed to reach steady state and 3 subsequent sample beats
were recorded and averaged. Measurements were made on
days 2 and 3. Fig. 6 A shows a representative shortening
amplitude-frequency response for a control myocyte on day
3. In agreement with previous work in primary culture, the
response was biphasic, with a decreasing amplitude re-
sponse observed between 0.2 and 1.0 Hz (Lim et al., 2000;
Hattori et al., 1991; Stemmer and Akera, 1986) and an
increasing amplitude response observed from 2.0 to 4.0 Hz
(Lim et al., 2000). Control (day 2), Lac-Z- (days 2 and 3),
and PV-expressing (day 2) myocytes exhibited similar re-
sults. However, by day 3 where PV expression is increased
(Fig. 2 B), the normalized amplitude response for the PV-
FIGURE 3 Calcium transients. (A) Representative calcium transients
from single cardiac myocytes (thick line, PV; dashed line, Lac-Z; thin line,
control; all data are from day 3); (B) Summary of the time from stimulus
to half-decay of the calcium transient for the three groups. Data from day
2 to 4 for Lac-Z and control myocytes were not different and were pooled,
whereas data for PV is shown for days 2–4 (n 105 for control and Lac-Z;
n 26, 48, and 49 for PV days 2, 3, and 4, respectively). Asterisks indicate
significant difference from pooled control (*p  0.01, **p  0.001).
Values are mean with SEM.
FIGURE 4 Calcium transient curve fitting. (A) All control, Lac-Z, and
20% of PV myocytes were well fit by single-exponential function; (B) The
remaining 80% of the PV population required a double-exponential fit; (C)
Summary of the fast (or single) time constant obtained with the fits. The
single time constant for control and Lac-Z myocytes showed no significant
difference between days after gene transfer and were pooled together. The
single and the fast (for the portion of the population that was better fit with
a double exponential) time constants are shown as function days after gene
transfer for PV-transduced myocytes. Number of samples from left to right
are n  105, 105, 4, 22, 11, 37, 10, and 39. Asterisks indicate significant
difference from pooled control (**p 0.001). Values are mean with SEM.
Optimal Range for Parvalbumin as Relaxing Agent 2571
Biophysical Journal 82(5) 2565–2579
expressing myocytes was flatter (Fig. 6 B). The tS-1/2R is
presented in Fig. 6 C (day 3). At 0.2 Hz, the PV expressing
myocytes showed a more rapid relaxation (as in Fig. 5B).
However, as the frequency increased, the tS-1/2R in PV-
expressing myocytes did not decrease as it did for Lac-Z and
control myocytes. Although the nature of the biphasic fre-
quency response of the control cardiac myocytes is still
unknown, a possible basis for the effects of PV on this
response is presented in the Discussion.
Mathematical models
Using mathematical models, we sought to obtain insights
into how PV concentration affects the shape and kinetics of
the calcium transient. One of the simplest models that could
be considered is the fixed calcium concentration model. In
this model, PV is submitted to a step function for the
calcium, and this value remains constant for the duration of
the step. Under these conditions, if the step is long enough,
FIGURE 5 Sarcomere shortening data. (A) Representative traces of con-
trol, Lac-Z, and PV-transduced cardiac myocytes (day 3); (B) Summary of
time from stimulus to half re-lengthening; (C) Summary of amplitude of
sarcomere shortening. Results for control (n  175; days 1–4 pooled) and
Lac-Z (n  149; days 1–4 pooled) myocytes and PV (n  54, 61, 52, 63,
and 59 for days 1, 2, 2.5, 3, and 4, respectively) are expressed as function
of days after gene transfer. Asterisks indicate significant difference from
pooled control (*p  0.05; **p  0.01; ***p  0.001). Values are mean
with SEM.
FIGURE 6 Sarcomere length shortening-frequency response. (A) Repre-
sentative SL shortening-frequency response for a control myocyte. The
amplitude of the shortening is displayed as function of time. Stimulus
frequencies are indicated. (B) Frequency response of sarcomere shortening
amplitude normalized to the 0.2-Hz value. Results are for control, Lac-Z,
and PV myocytes on day 3. (C) Time from stimulus to half re-lengthening
as a function of frequency for control (n  25), Lac-Z (n  26), and PV
(n  25) myocytes on day 3. Values are mean with SEM.
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the fractional binding variables of PV, Pvca and Pvmg,
reach a steady state (ss) value given by the following
equations:
Pvcass
Apvmg
1 1 Apvca1 Apvmg
(6)
Pvmgss
Apvca
1 1 Apvca1 Apvmg
, (7)
where:
Apvca
kpvca

kpvca
 
Ca
(8)
Apvmg
kpvmg

kpvmg
 
Mg
(9)
If we take the calcium concentration as a constant for the
duration of the step, the system of equations described by
Eqs. 1 and 2 becomes a set of coupled ordinary differential
equations. By using eigenvalue analysis, it is possible to
uncouple the equations and find the time constants required
to reach steady state. The time constants are given by:
where:
a11 kpvca
 
Ca kpvca
 (12)
a12 kpvca
 
Ca (13)
a21 kpvmg
 
Mg (14)
a22 kpvmg
 
Mg kpvmg
 (15)
Using the values for the different constants given in Meth-
ods, assuming a clamped value of [Ca2]  1.0 M, the
steady-state values for fractional binding become Pvcass 
0.782 and Pvmgss  0.209. The time constants obtained
with these values are   127.2 ms and   1.59 ms.
A simulation of a calcium clamp using the values men-
tioned above is presented in Fig. 7 A. As seen from the
simulation, only a small fraction of the PV population is
unbound. When the calcium level rises (inset), there is a
small decrease in the PV-free population toward the calci-
um-bound state. This transition occurs on the order of the
fast time constant (). However, this contribution is of
negligible amplitude. Most of the calcium buffering occurs
on a much slower time scale (), and Pvca takes its
increase mostly via a decrease in the Pvmg population, i.e.,
unbinding of magnesium from PV.
To obtain positive lusitropic effects (acceleration of the
decay/relaxation phase) without any reduction in contractile
amplitude the two following conditions must be met. 1) At
the peak of the calcium transient, the amount of calcium
buffered by PV must be small compared with the amount of
calcium buffered by troponin, calmodulin, and other endog-
enous buffers (to avoid a further reduction in amplitude). 2)
In the first part of the decaying phase, the amount of
calcium buffered by PV should be comparable to the
amount of calcium buffered by other buffers (to see a
significant increase in relaxation speed). Fig. 7 B illustrates
that point. A clamp of 150-ms duration at [Ca2]  1 M
was applied to the model (at [PV]  0.03 mM), and the
variation in the amount of calcium buffered by calmodulin
and troponin was also computed. At the point where a
typical rat calcium transient peak (Pk) would be (30 ms
after stimulus), the amount of calcium buffered by PV
corresponded to15% of the amount absorbed by the other
buffers. At the point where one-quarter decay (Dc) would
occur in rat cardiac myocytes (120 ms after stimulus) PV
buffered 38% of the amount buffered by the other calcium
buffers.
In controlling the effectiveness of the delayed calcium
buffer action, three parameters are of primary importance:
1) the variation in the fraction of PV sites occupied by
calcium during a single beat (Pvca), 2) the time constant
at which the binding occurs (mostly dominated by ), and
3) the PV concentration ([PV]). The amount of calcium
buffered by PV as a function of time is plotted in Fig. 7 C
for several different cases where the stimulus is a short
pulse-wave calcium clamp (duration 150 ms, frequency 1
Hz). The thick solid line represents the control case where
[PV] is 0.02 mM and all the parameters are set as mentioned
in Methods. The thin solid line represents the case where PV
concentration is halved to 0.01 mM. The thick dashed lined
represents the case where the rate constants were kpvca
 
2.69 s1, kpvmg
  4.81 s1 such that the time constant ()
was doubled. Finally, the thin dashed line represents the

2
a11 a22 a11 a222 4a11	 a22 a12	 a21 (10)

2
a11 a22 a11 a222 4a11	 a22 a12	 a21 (11)
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case where variation in the fraction of PV site population
occupied by calcium during a single beat (Pvca) was
halved again by adjusting the PV reaction rate constants
(kpvca
  2.44  108 M1 s1, kpvca
  8.06 s1, kpvmg
 
5.01  105 M1 s1, kpvmg
  7.30 s1). Basically, the
results show that each of these three parameters can be
varied such that they give a similar amount of calcium
buffered during a single beat. In the system that we are
currently using experimentally, the on and off rates of the
PV reaction are fixed leaving PV concentration (e.g., Fig. 2
B) as the only variable for a given calcium transient. How-
ever, one could envision mutations on the EF-hand motifs of
PV, which would modify the other parameters.
To investigate the sensitivity of the models, we examined
how changes in the model constants would affect the vari-
ation in fractional binding (Pvca). In Fig. 7 D, the steady-
state value of the fraction of the PV population bound to
calcium (Pvcass) is plotted as a function of calcium concen-
tration for four different cases. The vertical lines indicate,
respectively, diastolic (pCa 7.0) and systolic (pCa 6.0)
values of a typical calcium transient. The solid curve rep-
resents the response obtained with the model values as
described in Methods. The important parameter to consider
in this response is the variation in Pvcass between the two
vertical lines, which would be proportional to Pvca for a
given calcium transient. If the magnesium concentration is
doubled from 1 to 2 mM or if the value of the magnesium
affinity was increased or decreased by a factor of 5, the
Pvcass traces would change significantly as seen in Fig. 7 D.
However, the amount of variation in Pvca ss still remains at
similar levels even with large variations in these parameters.
This point emphasizes that even though the quantitative
values of the models are not exact, the qualitative results
obtained should still be significant.
Although the fixed calcium concentration model simula-
tions lend insight into the kinetics and amplitude in the
PV-binding population, it is very difficult to measure these
variables experimentally. Instead, one must rely on the
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FIGURE 7 Simulation of PV fractional binding to calcium and magnesium (fixed calcium concentration model). (A) Simulation of PV fractional binding
(main figure) when calcium is stepped from 0.1 to 1.0 M (inset); (B) Buffering capacity of PV. The traces represent the amount of calcium buffered by
PV (solid) and by troponin and calmodulin (dashed) during a short duration calcium clamp (150 ms at 2 Hz). Pk and Dc indicate where the peak and the
25% decay portion of a typical rat cardiac myocyte calcium transient would be. (C) Parameters that control calcium buffering by PV. Results show the
effects of halving [PV] (thin solid), doubling time constant  (thick dash) or halving Pvca (thin dashed) on the amount of calcium buffered by PV during
a pulse-wave calcium clamp (as in B). The thick solid line represents control case; see text for all details. (D) Effects of altered model parameters on PvcaSS.
The PV-Mg2 affinity constant was divided by 5 (dashed) or multiplied by 5 (dashed-dot), the magnesium concentration was doubled (dot). Results indicate
large changes in PvcaSS, but the amount of variation in PvcaSS between typical calcium transient diastolic and systolic values remains similar.
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effect of PV binding on the calcium transients to extract
useful information. The fixed calcium release model repre-
sents a simplified version of the myocyte environment.
Indeed, as mentioned in Methods, the model includes cal-
cium release and uptake compartments as well as buffering
by calmodulin, troponin, and PV. Fig. 8 A shows the effect
of PV concentration on the time course of the calcium
transient. The frequency of stimulus was chosen to be 0.2
Hz, and 20 cycles were allowed to reach a dynamic buff-
ering steady state. For [PV]  0.003 mM, PV has very little
effect on the calcium transient. For 0.003 mM 
 [PV] 
0.03 mM, there is an increase in the rate of decay with little
or no effects on the rising phase of the transient. As PV
increases above 0.03 mM, although the calcium transient
decays even faster, its amplitude is also reduced. To make
comparisons with the experimental results presented earlier,
the resulting calcium transient for the PV-free and [PV] 
0.03 mM simulations were normalized and are presented in
Fig. 8 B. Single- and double-exponential fits were per-
formed on the decay phase of the PV-free and [PV]  0.03
mM, respectively. By model construction, a decay time
constant () of 148.1 ms was obtained for the control
transient (PV free), which is comparable to the result ob-
tained experimentally (Table 1:   151.0 	 3.8ms). Using
the same stimulus, but increasing [PV] to 0.03 mM, pro-
duced results very similar to those obtained on day 3 (model
versus experimental results in Table 1: FAST  67.5 vs.
75.4 	 3.6ms, SLOW  401.5 vs. 898 	 72ms; relative
amplitude of the slow component: 14.9 vs. 11.9 	 1.1%).
However, Western blot results indicate an estimated PV
concentration of 0.099 	 0.012 mM, which is somewhat
higher than the 0.03 mM indicated by the model (Fig. 8 C).
Among the possible reasons for this discrepancy in the level
of [PV] required to reach similar response, is the degree of
uncertainty on the on and off rates in Eqs. 1 and 2. As
mentioned earlier, these values were extrapolated from ex-
perimental results obtained in different species under dif-
ferent temperature conditions. By simply dividing kpvca
 by
1.8 and kpvmg
 by 3.3 and increasing [PV] to 0.09 mM, a very
similar curve to the [PV]  0.03 mM curve presented in
Fig. 8 B was obtained (simulation results not shown because
the two curves almost overlap). Other issues regarding this
apparent mismatch will be presented in the Discussion.
The effects of altered stimulation frequency on the cal-
cium transient were also investigated using simulations. The
fixed calcium transient model was used to study the effect
of changes in Pvca during a single contraction. Fig. 9 A
shows the fixed calcium transient used as stimulus (4.0 Hz
shown). A minimum of 50 s (simulation time) was allowed
for the Pvca and Pvmg to reach their dynamic steady states.
After reaching the dynamic steady state, the amplitude of
Pvca was plotted against time (Fig. 9 B). As the frequency
of stimulation increased, the average level of PV occupation
by calcium increased. However, as the frequency increases
the variation in Pvca (Pvca) decreases (Fig. 9 C). As
mentioned earlier, for a given PV concentration, it is Pvca,
not the Pvca absolute value, that dictates how much calcium
can be buffered during a single beat. Therefore, for a given
PV concentration, calcium buffering capacity decreases as
stimulation frequency is increased.
FIGURE 8 Simulation of the buffering effects of PV on the calcium
transients (fixed calcium release model). (A) Effects of [PV] on the time
course of the calcium transient; (B) Normalized response from two of the
traces ([PV]  0.000 mM and 0.030 mM) displayed in A; (C) Comparison
between experimental and theoretical dose-response relationship for the
fast time constant of the decay. For [PV]  0.0 mM, the single time
constant was used.
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DISCUSSION
An important contribution of this study is that it establishes
for the first time the PV dose-response relationship in adult
cardiac myocytes. A combined approach of experimental
work and mathematical modeling was used to investigate
the quantitative effects of PV not only on relaxation but also
on contractile cellular properties. For the experimental
work, gene transfer technology was applied to isolated
cardiac myocytes from adult rats. The level of PV expres-
sion was varied by examining cardiac myocytes at different
time points after gene transfer, from initial detection (day 2)
to apparent saturation (day 4). This strategy is made possi-
ble by the high efficiency (95%) and synchronization of
PV gene transfer to cardiac myocytes. From these attributes
of gene transfer, we conclude that global quantitative anal-
ysis of PV expression is highly correlated to alterations at
the level of the single myocyte. We measured calcium
transient dynamics in single cardiac myocytes using the
fluorescent indicator fura-2 and unloaded shortening con-
traction properties using a laser diffraction system. Different
mathematical models, each incorporating equations of the
law of mass action for PV binding to calcium and magne-
sium, were used to gain mechanistic insights into PV func-
tion in cardiac myocytes.
Determining the optimal range for PV
functional effects
To establish the threshold effects of PV it was first ascer-
tained that for the non-transduced myocytes (controls),
there were no significant changes on any of the properties of
the shortening contraction from day 1 to 4 in primary
culture. This provided a unique and stable system to modify
PV expression by gene transfer. Second, using a virus
containing the Lac-Z gene neither the calcium kinetics nor
contractile function were affected, indicating no specific or
nonspecific effects of gene transfer on these parameters. In
this experimental setting, results demonstrated a specific PV
expression range where the tS-1/2R was decreased without
having any significant effects on contractile amplitude. This
occurred on day 2.5 after gene transfer (Fig. 5). On day 2.5,
the average estimated concentration of PV, as detected
using Western Blots, was 0.048 mM. At earlier time points,
and correspondingly lower levels of PV, there were no
significant alterations in relaxation in cardiac myocytes. At
later time points, where PV concentration was increased
(0.1 mM), relaxation rates further accelerated (Fig. 5).
However, at these higher concentrations of PV there was a
significant reduction in contractile amplitude. These results
suggest that the optimal range of PV expression, where
contraction is hastened without attenuation in amplitude, is
between 0.01 and 0.1 mM.
To gain mechanistic insights into the effects of PV on the
calcium transient, we constructed a mathematical model in
which PV buffering equations were mixed with a calcium
source, a calcium sink, and other cystolic calcium buffers
(troponin and calmodulin). This model had a fixed release
equation that was chosen to give a typical calcium transient
in the absence of PV. Using this constant calcium release
model, there were three different effects on the calcium
transients. At low PV concentrations ([PV] 
 0.003 mM),
FIGURE 9 Simulation of PV fractional binding to calcium as function of
stimulus frequency (fixed calcium transient model). (A) Fixed shaped
calcium transient used as control variable (example shown is at f  4.0
Hz); (B) Time course of the fractional binding of calcium to PV (Pvca)
when submitted to the fixed calcium transient at different frequencies
(traces shown under dynamic steady-state conditions); (C) Summary of the
amplitude of Pvca (variation in Pvca) for the different frequencies
modeled.
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little or no effect was seen. At intermediate levels (0.003
mM  [PV]  0.03 mM), there was an acceleration in the
calcium transient decay rate with little or no attenuation in
the amplitude of the transient. At higher concentrations
([PV]  0.03 mM), although the calcium transient had a
much faster decay, the amplitude started to decrease as the
PV level increased. This would lead to a theoretical optimal
range of PV concentration from 0.003 to 0.03 mM for which
the decay rate is quicker and amplitude not significantly
altered. This range is somewhat lower than the experimental
range mentioned above. Possible reasons for this discrep-
ancy will be discussed below.
PV causes a plateau in the SL shortening-
frequency relationship
In agreement with recent studies (Lim et al., 2000), control
cardiac myocytes exhibited a biphasic SL shortening-fre-
quency relationship. There was a negative staircase from 0.2
to 1.0 Hz, whereas the range from 2.0 to 4.0 Hz exhibited a
positive staircase. In PV-expressing myocytes the SL short-
ening-frequency relationship was mostly flat. Similar obser-
vations were made when the tS-1/2R was plotted as a function
of the frequency. Upon examination of the raw non-normal-
ized data, it was evident that PV-expressing myocytes have
a faster relaxation and a lower amplitude when compared
with the control myocytes at 0.2 Hz. However, when the
frequency increases, these functional differences tended to
decrease. Thus, the PV-expressing myocytes behaved more
similar to control myocytes in terms of relaxation kinetics at
the highest stimulation frequency.
In an attempt to understand the mechanism of this re-
sponse, mathematical modeling was used. The effect of
stimulation frequency on the fractional binding of calcium
to PV was investigated using the fixed calcium transient
model. This model was chosen to eliminate the variations in
the calcium transient due to PV buffering, thereby allowing
a fair comparison between simulation results at each fre-
quency. As shown in Fig. 9, Pvca (variation in fractional
binding of PV to calcium) decreases as the stimulation
frequency increases. This is due to the fact that the binding
and unbinding reactions from PV do not have time to come
to completion when the inter-beat duration is reduced. This
reduction in Pvca at high frequency, which would result in
an effectively lower amount of calcium buffered during the
decaying phase of the transient, could explain, at least in
part, why the PV myocytes tend to behave more similarly to
control myocytes. An interesting outcome of this analysis is
that PV would be predicted to have little effect on relaxation
function in transgenic mouse hearts in vivo because of the
high heart rates in mice (600 beats per minute). In con-
trast, it is expected that for equivalent PV concentrations,
the impact on relaxation would be greater in larger mam-
mals where the heartbeat is slower (60–100 beats per
minute).
Presence of PV changes the calcium
transient decay fit from single- to
double-exponential relationship
For all control myocytes and Lac-Z-transduced myocytes,
a single-exponential function was sufficient to accurately
fit the calcium transient decay data. However, for a large
portion of the PV myocytes studied (80%), using a
double-exponential function dramatically increased the
quality of the fit. The same phenomenon has been seen
experimentally in mouse skeletal muscle endogenously
expressing PV (Westerblad and Allen, 1994) or in rat
cardiac myocytes loaded with NP-EGTA (a slow calcium
buffer) that also produced a fast and a slow decay phase
(Diaz et al., 2001). In the present study, the PV-express-
ing myocytes had a fast decay component (87% of the
amplitude) with a time constant decreasing as the level of
PV increases. The slow component had a time constant of
much longer duration (900 ms for all days combined),
which seemed to be less dependent on absolute PV con-
centration. Using normalized calcium transient simula-
tion results, a similar behavior to those obtained experi-
mentally was observed. In particular, we examined two
simulated PV concentrations. At [PV]  0.0 mM (PV
free), the model gave very similar time constants to the
ones obtained in control myocytes experimentally. Next,
we increased PV concentration (the only free parameter)
until we had a behavior similar to day 3 experimental
data. Interestingly, the model also exhibited a clear dou-
ble-exponential decay curve (Fig. 8 B). At [PV]  0.03
mM, the fast component contribution and fast time con-
stant were also very similar to those obtained experimen-
tally (see Results). The slow time constant, even though
smaller, was of the same order of magnitude. The mech-
anism underlying the change from single-exponential fit
to double-exponential fit in the presence of PV could be
explained as follows. As described in the Introduction,
delayed calcium buffering by PV is responsible for the
strong buffering in the early decay phase of the transient.
However, when the calcium level starts to return to its
resting value the extra calcium absorbed by PV during
the rise and the early decay of the calcium transient is
now released in the late part of the cycle. This process is
also a slow one and is primarily dictated by the calcium
off rate constant from PV (modifying kpvca
 in the fixed
calcium release model had a major influence on the
amplitude and kinetics of the slow component of the
calcium transient, data not shown). Therefore, in the late
part of the cycle, PV acts as a slow source of calcium
release (not present in control myocytes). This source
effect is mostly responsible for the slower decay toward
the end of the cycle, explaining the presence of a second
(slow) exponential component.
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Limitations of the study
There are some limitations to this study. First, as mentioned
throughout the text, the on and off rates for PV-related
reactions were obtained under different conditions and thus
impact the quantitative simulation results. However, the
qualitative behavior of the models was certainly sufficient
to explain several of the phenomenon seen experimentally,
such as the effects of PV on calcium transient amplitude and
decay rate, the decreased effects of PV with increasing
stimulus frequency, and the transition in the calcium tran-
sient decay from single to double exponential when PV was
present.
Second, there was a discrepancy between the experimen-
tal and simulation determined optimal range of PV. This
could be due to the uncertainties in the quantitative results
of the models, but it should be also noted that the experi-
mentally determined PV concentration is only an estimate.
Indeed, the estimated level of PV expression was normal-
ized to actin in both the reference (SVL) and the PV-
transduced myocytes. Because there are more myofilament
proteins in fast skeletal muscles than in cardiac myocytes
(Bers, 2001), it is possible that the experimental PV con-
centration might have overestimated PV in the transduced
cardiac myocytes.
Finally, it should be pointed out that this study was
performed in rat adult cardiac myocytes in primary culture
under unloaded conditions. The optimal range of PV might
be different in cardiac myocytes from different species,
under loaded conditions, or in the intact heart.
Implications
Diastolic dysfunction is characterized by a slow relaxation
and is found in 40% of the patients with heart failure
(Lorell, 1991). In this and other studies (Wahr et al., 1999),
we have shown an increase in calcium transient decay rate
in isolated adult cardiac myocytes in the presence of PV.
More specifically, in the present study, we demonstrated
experimentally and theoretically that there exists a critical
PV concentration range for which the relaxation rate is
increased without attenuation in the contractile amplitude.
At PV levels below this critical range in PV concentration
there were no effects on contractile properties. Above this
critical range, the relaxation was further accelerated, but
there was also a significant reduction in contractile ampli-
tude. We recently demonstrated the effects of PV gene
transfer on contractile relaxation in vivo (Szatkowski et al.,
2001). The results showed not only a faster relaxation time
when compared with normal control rat hearts but also
increased contractile properties (higher dP/dt). The basis for
this latter effect is unknown but likely involves the com-
plexity of organ level function in intact animals, factors that
are missing in the isolated cardiac myocytes used in the
present study.
In summary, the present study demonstrates a critical PV
concentration range in isolated cardiac myocytes for which
the systolic parameters of the contraction remained unaf-
fected while diastolic relaxation was accelerated. This range
was determined experimentally to be 0.01–0.10 mM and
theoretically to be 0.003–0.030 mM. Establishing the ex-
pression threshold for PV exerting physiological effects has
implications for the use of PV as a cardiac relaxing factor in
normal and pathological states in vivo.
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